Litcius/Paper detail

Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low‐density lipoprotein receptor‐deficient mice

Anh T. P. Ngo, Kelley R. Jordan, Paul Müeller, Matthew Hagen, Stéphanie E. Reitsma, Cristina Puy, Alexey S. Revenko, Christina U. Lorentz, Erik I. Tucker, Quifang Cheng, Monica T. Hinds, Sergio Fazio, Brett P. Monia, David Gailani, András Gruber, Hagai Tavori, Owen J. T. McCarty

2021Journal of Thrombosis and Haemostasis55 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePrekallikreinInternal medicineEndocrinologyApolipoprotein BCoagulationLDL receptorLipoproteinImmunologyCholesterolBiologyBiochemistryKallikreinEnzymeCoagulation, Bradykinin, Polyphosphates, and AngioedemaHemophilia Treatment and ResearchThyroid and Parathyroid Surgery
Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low‐density lipoprotein receptor‐deficient mice | Litcius